Antineoplastic agent/Related Articles: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
No edit summary
 
(12 intermediate revisions by one other user not shown)
Line 10: Line 10:
==Subtopics==
==Subtopics==
===Alkylating agents===
===Alkylating agents===
====Nitrogen mustard agents====
====[[Nitrogen mustards]]====
{{r|Cyclophosphamide}}
{{r|Cyclophosphamide}}
{{r|Chlorambucil}}
{{r|Chlorambucil}}
{{r|Melphalan}}
{{r|Melphalan}}
{{r|Mechlorethamine}}
{{r|Chlormethine}}
{{r|Chlormethine}}
{{r|Ifosfamide}}
{{r|Ifosfamide}}
{{r|Trofosfamide}}
{{r|Trofosfamide}}
{{r|Prednimustine}}
{{r|Prednimustine}}
====Alkyl sulfonates====
====Alkyl sulfonates====
{{r|busulfan}}
{{r|busulfan}}
Line 26: Line 28:
{{r|Triaziquone}}
{{r|Triaziquone}}
{{r|Carboquone}}
{{r|Carboquone}}
====Nitrosoureas====
====Nitrosoureas====
{{r|Nitrosourea}}
{{r|Nitrosourea}}
Line 50: Line 51:
====Folic acid analogues====
====Folic acid analogues====
{{r|Folic acid}}
{{r|Folic acid}}
{{r|Folic acid analog antimetabolite}}
{{r|Folic acid antagonist}}
{{r|Methotrexate}}
{{r|Methotrexate}}
{{r|Raltitrexed}}
{{r|Raltitrexed}}
{{r|Pemetrexed }}
{{r|Pemetrexed }}
====Purine analogues====
====Purine analogues====
{{r|Purine analogue antimetabolite}}
{{r|Purine analogue antimetabolite}}
Line 82: Line 84:
ATC/DDD group L01CA.
ATC/DDD group L01CA.
====Podophyllotoxin derivatives====
====Podophyllotoxin derivatives====
{{r|Podophyllin}}
{{r|Etoposide}}
{{r|Etoposide}}
{{r|eniposide}}
{{r|Teniposide}}
 
====Colchicine derivatives====
====Colchicine derivatives====
{{r|Colchicine}}
{{r|Colchicine}}
ATC/DDD group L01CC.
{{r|Demecolcine}}
 
====Taxanes====
====Taxanes====
{{r|Paclitaxel}}
{{r|Docetaxel}}
{{r|Paclitaxel poliglumex}}


ATC/DDD group L01CD.
====Other plant alkaloids and natural products====
====Other plant alkaloids and natural products====
 
{{r|Trabectedin}}
ATC/DDD group L01CX.


===Cytotoxic antibiotics and related substances===
===Cytotoxic antibiotics and related substances===
ATC/DDD group L01D.
====Actinomycines====
====Actinomycines====
 
{{r|Dactinomycin}}
ATC/DDD group L01DA.
====Anthracyclines and related substances====
====Anthracyclines and related substances====
 
{{r|Doxorubicin}}
ATC/DDD group L01DB.
{{r|Daunorubicin}}
{{r|Epirubicin}}
{{r|Aclarubicin}}
{{r|Zorubicin}}
{{r|Idarubicin}}
{{r|Mitoxantrone}}
{{r|Pirarubicin}}
{{r|Valrubicin}}
====Other cytotoxic antibiotics====
====Other cytotoxic antibiotics====
{{r|Bleomycin}}
{{r|Plicamycin}}
{{r|Mitomycin}}
{{r|Ixabepilone}}


ATC/DDD group L01DC.
===Other antineoplastic agents===
===Other antineoplastic agents===


Line 139: Line 152:
{{r|Gemtuzumab}}is an "anti-CD33 (Entrez protein) antibody calicheamicin conjugate".[13]  
{{r|Gemtuzumab}}is an "anti-CD33 (Entrez protein) antibody calicheamicin conjugate".[13]  


=====Anti-CD52======
=====Anti-CD52=====
{{r|Alemtuzumab}}"a therapeutic antibody directed against the CDw52 antigen (Entrez protein) expressed by the lymphocytes and has proven lytic abilities both in vitro and in vivo; has been sequenced".[14]
{{r|Alemtuzumab}}


=====Anti-VEGF=====
=====Anti-VEGF=====
Line 146: Line 159:


===Sensitizers used in photodynamic/radiation therapy===
===Sensitizers used in photodynamic/radiation therapy===
{{r|porfimer sodium}}
{{r|methyl aminolevulinate}}
{{r|aminolevulinic acid}}
{{r|temoporfin}}
{{r|efaproxiral}}


ATC/DDD group L01XD.
===[[Protein kinase]] inhibitors===
===Protein kinase inhibitors===
{{r|Imatinib}}
{{r|Gefitinib}}
{{r|Erlotinib}}
{{r|Sunitinib}}
{{r|Sorafenib}}
{{r|Dasatinib}}
{{r|Lapatinib}}
{{r|Nilotinib}}
{{r|Temsirolimus}}


ATC/DDD group L01XE
{{r|imatinib}}
{{r|gefitinib}}
{{r|erlotinib}}
{{r|sunitinib}}
{{r|sorafenib}}
{{r|dasatinib}}
{{r|lapatinib}}
{{r|nilotinib}}
{{r|temsirolimus}}
==Other related topics==
==Other related topics==
{{r|Antiemetic}}
{{r|Antiemetic}}
{{r|Protein kinase}}
==Articles related by keyphrases (Bot populated)==

Latest revision as of 11:00, 11 July 2024

This article is developing and not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Antineoplastic_agent/Related_Articles&printable=yes
A list of Citizendium articles, and planned articles, about Antineoplastic agent.
See also changes related to Antineoplastic agent, or pages that link to Antineoplastic agent or to this page or whose text contains "Antineoplastic agent".


Parent topics

  • Cancer [r]: A generic term for a large group of diseases that can affect any part of the body; one defining feature is the rapid creation of abnormal cells that grow beyond their usual boundaries, and which can then invade adjoining parts of the body and spread to other organs. [e]
  • Immunology [r]: The study of all aspects of the immune system in all animals. [e]
  • Oncology [r]: The medical diagnosis and treatment of neoplasia, using pharmacologic, radiation, immunologic and surgical techniques; relevant formal subspecialties are medical oncology in internal medicine and radiation oncology in radiology; surgeons also may specialize in neoplasia [e]

Subtopics

Alkylating agents

Nitrogen mustards

Alkyl sulfonates

Ethylene imines

Nitrosoureas

Epoxides

Other alkylating agents

Antimetabolites

Folic acid analogues

Purine analogues

Pyrimidine analogues

Plant alkaloids and other natural products

Vinca alkaloids and analogues

ATC/DDD group L01CA.

Podophyllotoxin derivatives

Colchicine derivatives

Taxanes

Other plant alkaloids and natural products

Cytotoxic antibiotics and related substances

Actinomycines

Anthracyclines and related substances

Other cytotoxic antibiotics

Other antineoplastic agents

ATC/DDD group L01X.

Platinum compounds

ATC/DDD group L01XA.

Methylhydrazines

ATC/DDD group L01XB.

Monoclonal antibodies

ATC/DDD group L01XC. Examples include:

Anti-EGRF
Anti-EpCAM
Anti-ERBB2
Anti-CD3 and anti-EpCAM
  • Catumaxomab [r]: Add brief definition or description Is a monoclonal antibody against CD3 (Entrez protein)and EpCAM (Entrez protein). "Extracorporeal PBMNC coating with catumaxomab may be an option to control intravascular cytokine release induced by therapeutic antibodies".[11]
Anti-MS4A1 (CD20 antigen)
Anti-SIGLEC3 (CD33)
Anti-CD52
Anti-VEGF

Sensitizers used in photodynamic/radiation therapy

Protein kinase inhibitors

Other related topics

Articles related by keyphrases (Bot populated)

Retrieved from "https://citizendium.org/wiki/index.php?title=Antineoplastic_agent/Related_Articles&oldid=962311"